Shengtai Pharma sales revenue up 58% in FY2010
The increase in sales revenue resulted from the increase of the company’s sales volume and selling prices. Net profit for fiscal 2010 was $3.2m or 0.17 per share
miRecule has signed a research collaboration with EM subsidiary Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted ribonucleic acid (RNA) therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.
Medtronic’s IN.PACT drug-eluting balloons feature a hydrophilic coating called FreePac that frees and separates paclitaxel molecules, facilitating their absorption into the vessel wall to mitigate re-narrowing of the